Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tempei Miyaji

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 8, 2021
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving ChemoradiationTomoya Yokota, Sadamoto Zenda, Ichiro Ota, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2020
Patient-generated health data collection using a wearable activity tracker in cancer patients-a feasibility studyTempei Miyaji, Takashi Kawaguchi, Kanako Azuma, et al.
BMJ Open|November 4, 2019
A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) studyMasaki Fujiwara, Masatoshi Inagaki, Taichi Shimazu, et al.
BMC Cancer|February 1, 2023
Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastasesSadamoto Zenda, Yasunori Arai, Shunsuke Sugawara, et al.
Acta Psychiatrica Scandinavica|July 9, 2021
Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trialMasaki Fujiwara, Yuto Yamada, Taichi Shimazu, et al.
BMJ Open|June 14, 2022
Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trialYuto Yamada, Masaki Fujiwara, Taichi Shimazu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2022
Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)Tatsuo Akechi, Takuhiro Yamaguchi, Megumi Uchida, et al.
Trials|May 22, 2023
Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): a protocol for a randomized controlled trialMegumi Uchida, Toshiaki A Furukawa, Takuhiro Yamaguchi, et al.
BMJ Open|December 18, 2020
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapyHiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, et al.
Scientific Reports|October 14, 2016
Longer latency of sensory response to intravenous odor injection predicts olfactory neural disorderShu Kikuta, Yu Matsumoto, Akihito Kuboki, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|June 8, 2021
Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving ChemoradiationTomoya Yokota, Sadamoto Zenda, Ichiro Ota, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2020
Patient-generated health data collection using a wearable activity tracker in cancer patients-a feasibility studyTempei Miyaji, Takashi Kawaguchi, Kanako Azuma, et al.
BMJ Open|November 4, 2019
A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) studyMasaki Fujiwara, Masatoshi Inagaki, Taichi Shimazu, et al.
BMC Cancer|February 1, 2023
Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastasesSadamoto Zenda, Yasunori Arai, Shunsuke Sugawara, et al.
Acta Psychiatrica Scandinavica|July 9, 2021
Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trialMasaki Fujiwara, Yuto Yamada, Taichi Shimazu, et al.
BMJ Open|June 14, 2022
Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trialYuto Yamada, Masaki Fujiwara, Taichi Shimazu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2022
Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)Tatsuo Akechi, Takuhiro Yamaguchi, Megumi Uchida, et al.
Trials|May 22, 2023
Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): a protocol for a randomized controlled trialMegumi Uchida, Toshiaki A Furukawa, Takuhiro Yamaguchi, et al.
BMJ Open|December 18, 2020
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapyHiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, et al.
Scientific Reports|October 14, 2016
Longer latency of sensory response to intravenous odor injection predicts olfactory neural disorderShu Kikuta, Yu Matsumoto, Akihito Kuboki, et al.
Pageof 6